BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24732594)

  • 1. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
    Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
    Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
    Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
    Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
    Lerner M; Harada M; Lovén J; Castro J; Davis Z; Oscier D; Henriksson M; Sangfelt O; Grandér D; Corcoran MM
    Exp Cell Res; 2009 Oct; 315(17):2941-52. PubMed ID: 19591824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
    Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large fraction of trisomy 12, 17p
    Pepe F; Rassenti LZ; Pekarsky Y; Labanowska J; Nakamura T; Nigita G; Kipps TJ; Balatti V; Croce CM
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
    Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
    PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
    Hanlon K; Rudin CE; Harries LW
    PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
    Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
    Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2011 Nov; 17(21):6778-90. PubMed ID: 21890456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia.
    Yılmaz M; Kuru RD; Erdoğan I; Soysal T; Hacıhanefioglu S; Baykara O
    Afr Health Sci; 2022 Sep; 22(3):173-182. PubMed ID: 36910369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
    Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
    Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
    Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
    Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia and 13q14: miRs and more.
    Mertens D; Philippen A; Ruppel M; Allegra D; Bhattacharya N; Tschuch C; Wolf S; Idler I; Zenz T; Stilgenbauer S
    Leuk Lymphoma; 2009 Mar; 50(3):502-5. PubMed ID: 19347735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
    Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
    Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.